Your Messages Inbox
Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. 2008 Exclusive Survey—Earnings: Good news for primary care income 3. Medicare pay-for-reporting effort draws fire from frustrated doctors 4. Debunking Myths in the US Healthcare System 5. Statins and cancer risk
Your Article Summary
See Latest ArticlesFirst Patient Enrolled in Phase 3 Trials of Genzyme Oral Capsule for Gaucher Disease
Genzyme, 10/21/09
Genzyme Corporation announced that the company has begun enrollment in the first of two global, multi–center, phase 3 trials of Genz–112638, a potential new oral therapy for Gaucher disease type 1. The two multi–national, multi–center trials are being conducted to evaluate the safety and efficacy of the small molecule.
Today in Drug Trials...keeping you current
Receive free subspecialty "5-minute updates" via email
Bioequivalence of two film-coated tablets of imatinib mesylate 400 mg: A randomized, open-label, single-dose, fasting, two-period, two-sequence crossover comparison in healthy male South American volunteers
Clinical Therapeutics, 12/01/09
Directly observed antiretroviral therapy: a systematic review and meta-analysis of randomised clinical trials
The Lancet - Early Online Publication, 12/01/09
Bayer Starts Phase III Trial with Florbetaben
BayNews International, 12/01/09
Sponsor
Article Search
Sponsor